BASAL CELL CARCINOMA METASTATIC

BASAL CELL CARCINOMA METASTATIC was reported 17 times

BASAL CELL CARCINOMA METASTATIC is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CEMIPLIMAB-RWLC 2 0.0010
1 ADALIMUMAB-ATTO 1 0.0006
2 VISMODEGIB 4 0.0004
3 NICOTINAMIDE 1 0.0004
4 BUROSUMAB 2 0.0003
5 ACITRETIN 1 0.0002
6 PHENYTOIN 1 0.0000
7 RIBOCICLIB 1 0.0000
8 LETROZOLE TABLETS 1 0.0000
9 CYCLOSPORINE 2 0.0000
10 LETROZOLE 1 0.0000
11 OCRELIZUMAB 1 0.0000
12 DENOSUMAB 3 0.0000
13 FLUOROURACIL CREAM, 0.5% 1 0.0000
14 FLUOROURACIL 1 0.0000
15 NIVOLUMAB 1 0.0000
16 USTEKINUMAB 1 0.0000
17 MYCOPHENOLATE MOFETIL 1 0.0000
18 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 0.0000
19 SECUKINUMAB 1 0.0000
20 INFLIXIMAB 1 0.0000
21 INSULIN GLARGINE 1 0.0000
22 FOLIC ACID 1 0.0000
23 PANTOPRAZOLE 1 0.0000
24 AMLODIPINE 1 0.0000
25 DEXAMETHASONE 1.5 MG 1 0.0000
26 ETANERCEPT 2 0.0000
27 DEXAMETHASONE 1 0.0000
28 METHOTREXATE SODIUM 1 0.0000
29 PREDNISONE 1 0.0000
30 ADALIMUMAB 1 0.0000